These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18353149)

  • 1. An objective method for the assessment of vitiligo treatment.
    Marrakchi S; Bouassida S; Meziou TJ; Turki H; Zahaf A
    Pigment Cell Melanoma Res; 2008 Feb; 21(1):106-7. PubMed ID: 18353149
    [No Abstract]   [Full Text] [Related]  

  • 2. Independent component analysis for assessing therapeutic response in vitiligo skin disorder.
    Fadzil MH; Norashikin S; Suraiya HH; Nugroho H
    J Med Eng Technol; 2009; 33(2):101-9. PubMed ID: 19205989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computerised image analysis of vitiligo lesion: evaluation using manually defined lesion areas.
    Nugroho H; Ahmad Fadzil MH; Shamsudin N; Hussein SH
    Skin Res Technol; 2013 Feb; 19(1):e72-7. PubMed ID: 22233154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitiligo: new and emerging treatments.
    Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
    Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's new in the treatment of vitiligo.
    Falabella R
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):287-9. PubMed ID: 11730030
    [No Abstract]   [Full Text] [Related]  

  • 6. A pilot study to determine vitiligo target size using a computer-based image analysis program.
    Sheth VM; Rithe R; Pandya AG; Chandrakasan A
    J Am Acad Dermatol; 2015 Aug; 73(2):342-5. PubMed ID: 26183989
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy evaluation in dermatology by comparative color measurements].
    Meffert B; Hochmuth O; Hongsanant A; Schmollack KP
    Biomed Tech (Berl); 1998; 43 Suppl():82-3. PubMed ID: 9859268
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
    Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
    Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma.
    Vanscheidt W; Hunziker T
    Dermatology; 2009; 218(4):342-3. PubMed ID: 19174603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultraviolet radiation sensitivity in vitiligo and adjacent normal skin.
    Oh C; Hennessy A; Rees JL
    Acta Derm Venereol; 2006; 86(4):380. PubMed ID: 16874438
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on skin repigmentation therapies in vitiligo.
    Falabella R; Barona MI
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple quantitative assessment for repigmentation in vitiligo.
    Sohail A; Vaqas B; Bodeker G; Ryan T
    Int J Dermatol; 2012 Mar; 51(3):360-1. PubMed ID: 22348581
    [No Abstract]   [Full Text] [Related]  

  • 14. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo.
    Chimento SM; Newland M; Ricotti C; Nistico S; Romanelli P
    J Drugs Dermatol; 2008 Mar; 7(3):258-63. PubMed ID: 18380207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous repigmentation in vitiligo: why it is important.
    Malakar S; Lahiri K
    Int J Dermatol; 2006 Apr; 45(4):478-9. PubMed ID: 16650185
    [No Abstract]   [Full Text] [Related]  

  • 16. Dihydroxyacetone: a safe camouflaging option in vitiligo.
    Rajatanavin N; Suwanachote S; Kulkollakarn S
    Int J Dermatol; 2008 Apr; 47(4):402-6. PubMed ID: 18377610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
    Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of autologous minigrafts for the treatment of large-area segmental vitiligo.
    Sun X; Wu Y; Qian G; Xu A
    J Dermatolog Treat; 2009; 20(4):248-50. PubMed ID: 19107629
    [No Abstract]   [Full Text] [Related]  

  • 19. Chinese cupping: a simple method to obtain epithelial grafts for the management of resistant localized vitiligo.
    Awad SS
    Dermatol Surg; 2008 Sep; 34(9):1186-92; discussion 1192-3. PubMed ID: 18537996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New and experimental treatments of vitiligo and other hypomelanoses.
    Lotti T; Prignano F; Buggiani G
    Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.